Top Markets
#1 Black Phoenix Black Phoenix +167.06%
#2 Islamic Coin Islamic Coin +158.25%
#3 Glidr Glidr +84.34%
#4 Acurast Acurast +38.72%
#5 Test Test +21.35%
#6 Cryptopia Cryptopia +20.92%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.45%
#8 Quantum Resistant Ledger Quantum Resistant Ledger +12.43%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +9.97%
#10 stake.link stake.link +9.30%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
CannAmerica Brands Corp. CannAmerica Brands Corp.

CannAmerica Brands Corp.

CNNXF
Rank in Stocks #42596
CannAmerica Brands Corp. owns a portfolio of brands of medical cannabis and... CannAmerica Brands Corp. owns a portfolio of brands of medical cannabis and recreational cannabis products. The company primarily builds and maximizes the value of its brands by promoting, marketing, and licensing brands through various distribution channels, including dispensaries, wholesalers, and distributors in the states of Colorado, Nevada, Oklahoma, and Massachusetts. It offers cannabis infused gummy products, disposable vape pens, distillate droppers, and shatter and wax concentrate products under the CannAmerica brand. The company is headquartered in Vancouver, Canada.
Share Price
$0.00001
Last synced: 2026-08-11
Market Cap
$704.00
Change (1 day)
0.00%
Change (1 year)
900.00%
Country
CA
Trade CannAmerica Brands Corp. (CNNXF)

Category

Healthcare
Revenue for CannAmerica Brands Corp. (CNNXF)
Revenue in Aug 2026 TTM: 0
According to CannAmerica Brands Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CannAmerica Brands Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US